|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 76.4 TWD | -0.13% |
|
-0.52% | -13.18% |
Pharmosa Biopharm Inc. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported net loss was TWD 130.85 million compared to TWD 159.27 million a year ago. Basic loss per share from continuing operations was TWD 1.18 compared to TWD 1.63 a year ago.
Diluted loss per share from continuing operations was TWD 1.18 compared to TWD 1.63 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -13.18% | 303M | |
| +43.36% | 54.64B | |
| -5.31% | 39.92B | |
| +37.52% | 38.82B | |
| +14.75% | 26.86B | |
| -12.56% | 26.22B | |
| -22.45% | 18.78B | |
| +0.04% | 12.16B | |
| +25.12% | 12.21B | |
| +26.04% | 11.94B |
PHARMOSA BIOPHARM INC. 
